News & Articles
Outsourcing Vendor Red Flag #2: Layers of Oversight And Process Are Impeding My Program
Depth of management typically is less about ensuring your trial progresses smoothly […]
Read More....Outsourcing Vendor Red Flag #3: A Bid Is Inaccurate Or Suspiciously Low
Adept CRO communication doesn’t just indicate the vendor’s ability to deliver a […]
Read More....Strategies for a More Secure Outsourcing Bottom Line
The article discusses strategies for securing a more stable and cost-effective outsourcing […]
Read More....Leveraging Clinical Trial Data In Real Time To Effect Change And Mitigate Risk
The article discusses the untapped potential of real-time clinical trial data analytics […]
Read More....Why Collaborative Protocol Design Is Vital To Autologous Cell Therapy Clinical Trials
Collaborative protocol design is essential in the development of autologous cell therapy […]
Read More....Remote Clinical Trial Monitoring: CRA Success In An Era Of Autonomy
The COVID-19 pandemic has accelerated the adoption of remote work in clinical […]
Read More....Why Site And Partner Communications Are Critical To Autologous Cell Therapy Clinical Trials
Effective communication between clinical trial sites and partners is crucial for the […]
Read More....Time, Logistics, And Manufacturing In Autologous Cell Therapy Clinical Trials
Efficient time management, streamlined logistics, and standardized manufacturing processes are critical for […]
Read More....Clinical Research Considerations For Rare Disease Patients: Part 1 — Reinvigorate Patient Centricity
The article emphasizes the need for a shift towards patient-centric approaches in […]
Read More....Clinical Research Considerations For Rare Disease Patients: Part 2 — The Impact Of Physician And Site Support
Physician and site support are critical for the success of rare disease […]
Read More....